Home » Topics » BioWorld Science

BioWorld Science
RSS

LG Chem selects preclinical candidate from PD-L1/XT program with Avacta

Sep. 29, 2021

Interim data on psilocybin plus NAC in rodent model of mild TBI and PTSD

Sep. 29, 2021

Gamida Cell announces new NK cell construct development programs

Sep. 29, 2021

SBIR grant supports Senti's development of CAR-NK cell therapy SENTI-202 for AML

Sep. 29, 2021

Point Biopharma reports preclinical data on FAP-alpha inhibitor program

Sep. 29, 2021

RARA identified as a druggable target for pediatric acute myeloid leukemia

Sep. 29, 2021

Mitochon announces funding to support development of MP-201 for TBI

Sep. 29, 2021

Shionogi licenses S-365598 to ViiV for use in ultra long-acting HIV regimens

Sep. 29, 2021

Intranasal subunit SARS-CoV-2 vaccines elicit mucosal and systemic immunity in vivo

Sep. 29, 2021

Targeting KIR3DS1/HLA-F axis as new therapeutic strategy against human adenovirus infections

Sep. 29, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 10, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026